| Literature DB >> 23864839 |
Ariadna Garza-Ortiz1, Carlos Camacho-Camacho, Teresita Sainz-Espuñes, Irma Rojas-Oviedo, Luis Raúl Gutiérrez-Lucas, Atilano Gutierrez Carrillo, Marco A Vera Ramirez.
Abstract
Five novel tin Schiff base complexes withEntities:
Year: 2013 PMID: 23864839 PMCID: PMC3707209 DOI: 10.1155/2013/502713
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Figure 1Schematic representation of compounds 1–5 and their synthetic procedure.
Figure 2Observed mass spectrum (a) and simulated spectrum (b) of complex 1.
Figure 3Observed mass spectrum (a) and simulated spectrum (b) of complex 2.
1H NMR data of compounds 1–5.
| Compound numbering |
|
|
|
|
|---|---|---|---|---|
| H11 | 8.13 (s, 1H) [58] | 7.91 (s, 1H) [52] | 8.33 (s, 1H) [70] | 8.34 (s, 1H) |
| H17 | 7.63 (s, 1H) | 7.60 (s, 1H) | 7.08 (s, 1H) | 7.48 (s, 1H) |
| H5 | 7.54 (d, 1H) [2.4] | 7.51 (d, 1H) [2.7] | 7.63 (d, 1H) [2.4] | 7.35 (d, 1H) [2.4] |
| H3 | 6.85 (d, 1H) [2.4] | 6.76 (d, 1H) [2.7] | 7.07 (d, 1H) [2.5] | 7.03 (d, 1H) [2.4] |
| H19 | 6.80 (s, 1H) | 6.73 (s, 1H) | 6.52 (s, 1H) | 6.73 (s, 1H) |
| H12 | 4.43 (m, 1H) | 4.43 (m, 1H) | 4.59 (m, 1H) | 4.14 (m, 1H) |
| H14 | 3.39–3.25 | 3.47–3.44 | 3.27–3.16 | 3.31–3.15 |
| H | 1.73–1.51 | 1.27–1.28 | ||
| H | 1.4–1.3 (m, 4H) | 1.27–1.28 (m, 6H) | ||
| H | 1.4–1.3 (m, 4H) | 1.53 | ||
| H | 0.92 (t, 3H) [7.3] | 0.80 (t, 9H) [7.3] | ||
| Ho | 7.87–7.82 | |||
| Hm | 7.58–7.29 | |||
| Hp | 7.58–7.29 | |||
| H8, H10 | 1.37 (s, 9H) | 1.37 (s, 9H) | 1.47 (s, 9H) | 1.41 (s, 9H) |
| CH3-Sn | 0.64 (s, 6H), |
Data obtained at 500 MHz. Chemical shifts in ppm with respect to TMS; coupling constants in hertz, J(1H–1H) and J(1H–119/117Sn) between brackets.
s: singlet; d: doublet; t: triplet; m: complex pattern. Assignment base in 1D and 2D NMR studies.
13C and 119Sn NMR data of compounds 1–5.
| Compound numbering |
|
|
|
|
|
|---|---|---|---|---|---|
| C11 | 174.33 | 174.54 | 177.66 | 167.57 | 166.6 |
| C13 | 173.72 | 173.72 | 175.79 | 175.62 | 176.6 |
| C2 | 166.59 | 167.0 | 168.61 | 158.13 | 157.55 |
| C1 | 141.29 | 140.96 | 143.61 | 140.00 | a |
| C4 | 139.04 | 138.64 | 142.00 | 136.67 | a |
| C6 | 135.70 | 135.67 | 134.63 | 134.09 | a |
| C5 | 133.19 | 133.08 | 132.97 | 127.16 | a |
| C17 | 131.08 (b) | 131.30 (b) | 132.64 (b) | 131.98 (b) | — |
| C3 | 129.49 | 129.47 | 129.95 | 126.24 | a |
| C19 | 119.78 (b) | 119.84 (b) | 118.00 (b) | 123.69 (b) | 120.2 |
| C15 | 116.61 | 116.51 | 119.66 | 117.98 | 117.5 |
| C12 | 67.18 | 67.42 | 68.56 | 72.02 | 64.0 |
| C7 | 35.27 | 35.19 | 35.45 | 35.08 | 34.68 |
| C9 | 34.06 | 33.93 | 34.17 | 34.16 | 33.86 |
| C14 | 33.97 | 33.90 (b) | 33.98 | 29.50 (b) | 29.5 |
| C8 | 31.23 | 31.10 | 30.56 | 31.54 | 31.0 |
| C10 | 29.44 | 29.36 | 29.47 | 29.50 | 29.2 |
| CH3 | 1.23, 0.933 [653/648] | ||||
| C | 27.00 [38] | 28.07 [24] | |||
| C | 26.74 [91] | 27.02 [72/70] | |||
| C | 22.26 [599] | 17.73 [435/415] | |||
| C | 13.59 | 13.66 | |||
| Ci | 142.67 [n.o.] | a | |||
| Co | 137.78 [53] | a | |||
| Cm | 130.54 [87] | a | |||
| Cp | 132.12 [n.o.] | a | |||
| 119Sn | −162.16 | −197.58 | −369 | 39.44 | No soluble |
|
119Sn | −169.50 | −196.68 | −455.87 | −112.59 | −122.09 |
Chemical shifts in ppm with respect to TMS; 119Sn chemical shifts in ppm with respect to (CH3)4Sn; J(13C–119/117Sn) coupling constants between square brackets. n.o.: not observed.
a: Unambiguous assignment of this resonance peak was not reached because there are multiple broad signals included in the range 143–127 ppm.
Figure 4Numbering system used in pentacoordinated and tetracoordinated tin(IV) compounds for the NMR spectra assignment. R = CH3–, CH3CH2CH2CH2– (CHα, CHβ, CHγ, CHδ) or C6H5– (CHo, CHm, CHp).
Antimicrobial activity of organotin(IV) compounds 1–5.
| Strain | Compound | ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| + | − | − | ++ | +++ |
|
| + | + | − | − | − |
|
| + | − | − | − | − |
|
| − | + | − | − | − |
|
| − | + | − | − | − |
|
| − | + | − | − | − |
|
| − | + | − | − | − |
|
| − | − | − | − | − |
|
| − | − | − | − | + |
Figure 5Photographs of the antimicrobial activities of compounds 1, 2, and 3 against S. aureus, P. mirabilis, S. typhimurium, P. aeruginosa, S. dysenteriae, and S. typhi, showing their inhibition zone.
Figure 6Photographs of the antimicrobial activities of compounds 4 and 5 against S. aureus, P. mirabilis, S. typhimurium, P. aeruginosa, S. dysenteriae, and S. typhi, showing their inhibition zone.